Daniel S. Jonas - Mar 4, 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
EVP Legal Affairs,Gen. Counsel
Signature
/s/ Sarah M. Oliker for Daniel S. Jonas by Power of Attorney
Stock symbol
CNMD
Transactions as of
Mar 4, 2022
Transactions value $
-$1,677,044
Form type
4
Date filed
3/8/2022, 03:18 PM
Previous filing
Mar 3, 2022
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $58.3K +1.39K +11.42% $41.93 13.6K Mar 4, 2022 Direct
transaction CNMD Common Stock Sale -$199K -1.39K -10.25% $143.30 12.2K Mar 4, 2022 Direct F1
transaction CNMD Common Stock Options Exercise $151K +3.61K +29.67% $41.93 15.8K Mar 4, 2022 Direct
transaction CNMD Common Stock Sale -$514K -3.61K -22.88% $142.42 12.2K Mar 4, 2022 Direct F2
transaction CNMD Common Stock Options Exercise $336K +5.6K +46.03% $59.96 17.8K Mar 4, 2022 Direct
transaction CNMD Common Stock Sale -$798K -5.6K -31.52% $142.50 12.2K Mar 4, 2022 Direct
transaction CNMD Common Stock Options Exercise $879K +11.2K +91.7% $78.76 23.3K Mar 4, 2022 Direct
transaction CNMD Common Stock Sale -$1.59M -11.2K -47.83% $142.50 12.2K Mar 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1.39K -27.8% $0.00 3.61K Mar 4, 2022 Common Stock 1.39K $41.93 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -3.61K -100% $0.00* 0 Mar 4, 2022 Common Stock 3.61K $41.93 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5.6K -50.91% $0.00 5.4K Mar 4, 2022 Common Stock 5.6K $59.96 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -11.2K -52.73% $0.00 10K Mar 4, 2022 Common Stock 11.2K $78.76 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.28 to $143.34. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.40 to $142.54. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F4 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period